CD79A and IgA glomerulonephritis: Our study benefits from our larger sample size and the strict design as a multicenter, three-group-parallel study with placebo controls, and we will observe the effects of ART on the serum Gd-IgA levels in patients with IgA nephropathy, which will help us better understand the proteinuria reduction effect of ART and its possible mechanism.